# Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas

> **NCT07649070** · PHASE2 · NOT_YET_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 38 (estimated)

## Conditions studied

- High Grade Gliomas

## Interventions

- **DRUG:** G207

## Key facts

- **NCT ID:** NCT07649070
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-30
- **Primary completion:** 2030-12-31
- **Final completion:** 2032-12-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07649070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07649070, "Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07649070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*